The product of the envelope gene (gp55) of Friend spleen focus-forming virus is responsible for the acute form of erythroleukaemia caused by this virus. In order to investigate the role that the four known N-linked carbohydrate side-chains of gp55 play in pathogenesis, we have inactivated the four N-glycosylation signals by mutating the asparagine residues of these four sites into serine. When glycosylation sites 1 and/or 2 were altered, the viruses remained fully pathogenic. However, mutation at either of glycosylation sites 3 or 4 rendered the virus apathogenic, independent of mutations at other sites. Furthermore, when site 3 was changed, a new product appeared which seemed to have acquired a carbohydrate chain at a position normally not glycosylated, presumably at position Asn~Ts.
Introduction
Friend spleen focus-forming virus (F-SFFV) is a highly pathogenic, replication-defective retrovirus inducing acute erythroleukaemia in mice which is either associated with a polycythaemia (F-SFFVp) or a slight anaemia (for reviews, see Ruscetti & Wolff, 1984; Ostertag et al., 1987; Kabat, 1989) . In both instances, the presence and expression of the viral envelope (env) gene was shown to be essential and sufficient for induction of the disease (Linemeyer et al., 1981 (Linemeyer et al., , 1982 Machida et al., 1985; Wolff & Ruscetti, 1985 Li et al., 1986) . It has been further demonstrated that the large deletion and the frameshift mutation near the 3' end of the SFFV env gene are the essential determinants for the high degree of pathogenicity of these viruses (Friedrich et al., 1991; Watanabe et al., 1991 ).
The precise mechanism by which SFFV causes erythroleukaemia remains unknown. The available evidence, however, indicates that the SFFV env gene product interacts with the cellular erythropoietin receptor (Li et al., 1990; Yoshimura et al., 1990; Casadevall et al., 1991) leading in the case of SFFVp to an erythropoietin-independent proliferation of the cells (Ruscetti et al., 1990; Hoatlin et al., 1990) . This factorindependent growth is primarily determined by the transmembrane domain of the envelope protein (Chung et al., 1989) . The resulting erythroblastosis may be an important step in induction of the disease. At a later stage, erythroblast immortalization seems to occur as a consequence of specific integration of the provirus within the cellular genome (Spiro et al., 1988) , activating the putative oncogene Spi-1 (Moreau-Gachelin et al., 1988; Paul et al., 1991) .
The F-SFFV F env gene encodes a glycoprotein with five potential glycosylation sites (Amanuma et al., 1983; Clark & Mak, 1983; Wolff et al., 1983) . The primary gene product formed has an apparent Mr of 55000 (gp55) and carries solely high-mannose type glycans (Ruta et al., 1982; Srinivas & Compans, 1983; Strube et al., 1988) . The majority of gp55 accumulates intracellularly. Only a small proportion of the molecules is further processed in the Golgi apparatus yielding a glycoprotein with an Mr of about 65 000 (gp65) which carries complex-type carbohydrate chains (Srinivas & Compans, 1983; Strube & Geyer, 1989) as well as Olinked glycans (Pinter & Honnen, 1989; Gliniak & Kabat, 1989) and can be readily detected on the cell surface . It has been suggested that the surface expression of gp65 (Li et al., 1987) and, possibly, also shedding of the molecule from the plasma membrane by proteolytic cleavage of the membrane anchor from the C terminus (Pinter & Honnen, 1985 , 1989 Gliniak & Kabat, 1989 ) may be a prerequisite for the leukaemogenicity of F-SFFV F. Hence, intracellular transport and processing of the env gene product seem to be important for viral pathogenicity.
Gp55 as well as gp65 have been shown to form disulphide-bonded homooligomers inside the cell (Gliniak & Kabat, 1989; Kilpatrick et al., 1989; Yang et al., 1990; Gliniak et al., 1991) . Further evidence indicates that gp55 folds into different disulphide-linked components, whereas only one specific dimer is formed in the case of gp65, suggesting that only a distinct In order to study the possible biological functions of the carbohydrate moieties of SFFVp Env proteins for viral pathogenicity, we have created nine mutant viruses encoding glycoproteins that lack distinct potential Nglycosytation sites. Consensus sequences (Asn-X-Thr/ Ser) were destroyed by replacing Asn4~, Asnss , Asn~97 and/or Asna29 by Ser. Since the potential glycosylation site at Asn37 s is generally considered not to be glycosylated (Kabat, 1989) , this part of the molecule was not mutated. Pathological properties of mutant and wild-type viruses were compared.
Methods
Construction of glycosylation mutants of the SFFV env gene. To alter the consensus sites for N-glycosylation of the SFFV env gene product we used either site-directed mutagenesis (Asn43 and Asn58 ) or (Asn2~ 7 and Asn329) (positions are counted from the initiator methionine; subtract 32 for positions in the mature gp55). The plasmid pSAX encoding a molecular clone of the F-SFFV has been described previously (Friedrich et al., 1991) and was the starting material for the following studies. A 2.1 kb XmalII/Aat]I fragment containing the entire SFFV env gene was recloned in pUCI3 (Pharmacia) leading to a plasmid designated pUSAX which was then used for mutagenesis. An Eagl restriction fragment containing the mutated sites was then transferred back into pSAX.
Oligonucleotide-directed mutagenesis. A BamHI/Ahall fragment (572 bp) containing the sequences encoding Asn4a and Asn~s was inserted into M 13mp 18. Mutagenesis was carried out by the method of Taylor and Eckstein (Taylor et al., 1985) utilizing the Amersham oligonucleotide-directed /n vitro mutagenesis system. Two synthetic oligonucleotide primers were used to mutate the Asn-X-Ser/Thr N-glycosylation signals, each having a single base mismatch to change asparagine into serine [primer for glycosylation site 1 (Asn43): CAAGTAACACTGAAGAC; site 2 (Asn~8): GGTAGCGCTAG-CTGTTTG).
Mutagenesis by the polymerase chain reaction. To eliminate the two consensus sites for N-glycosylation at Asn297 and Asn329, we employed the PCR using the following pair of primers, each having a single base mismatch to change the asparagine into a serine residue: glycosylation site 3 (Asn29r): GCTCTCAGCCTCACCAAC and TGGTGAGGC-TGAGAGCTTGG; glycosylation site 4 (Asn329): TATTTTAGT-CATACCATTGCCCTA and GCAATGGTATGACTAAAATAAG. For amplification of the PCR fusion product, two external primers were used (PI: ATCATCATCATGGGACCTAATT; P2: TTTGG-TATTTTTCCATGCCTTGC). The plasmid pUSAX was linearized with KpnI. Amplification of the DNA fragments from the plasmid template was achieved by adding 1 ng of template DNA, 0.25 pM of each primer and 2.5 units Taq polymerase (Perkin-Elmer Cetus) to a final volume of 50 lal, 50 mM-KCI, 10 mM-Tris-HC1 pH 8.6, 1.5 mMMgC12 and 200 laM of each dNTP. These samples were overlaid with 100 gl paraffin and subjected to 25 cycles of denaturation (1 rain, 95 °C), annealing (1 rain, 56 °C) and extension (3 min, 72 °C). Reaction products were analysed on gels containing 1.5 % agarose and 1 lag/ml ethidium bromide in Tris borate buffer (45 gM-Tris-borate, 1 laM-EDTA). Samples of 5 gl (or dilutions thereof) of the three PCR reaction mixtures containing the overlapping fragments were mixed and subjected to PCR amplification using the external primers (P1 and P2) which were complementary to sequences located approximately 100 bp (for P2 300 bp) outside of the unique EcoRI and AsulI restriction sites, thus making it possible to ligate the mutated fusion product from the overlap extension reaction into the expression vector. DNA fragments were purified from agarose by using glass powder according to Vogelstein & Gillespie (1979) .
Analysis of the DNA constructs. Mutations at amino acid positions 58, 297 and 329 created or destroyed restriction enzyme sites which facilitated screening of the mutants. All mutations and all sequences of DNAs synthesized by PCR were confirmed by sequencing with the dideoxynucleotide method (Sanger et al., 1977) .
Transfection procedure and cell culture. The SphI fragment of pSAX containing the whole viral genome was ligated into concatemers which were used for transfection of Rat-1 cells essentially as described previously (Friedrich et al., 1991 ) . Transfection with plasmid DNA was performed by lipofection (Felgner et al., 1987) , using 5 lag of viral DNA in the presence of 0.1 lag of a plasmid DNA containing the gene for neomycin resistance. The transfection reagent DOTMA was obtained from Boehringer. Rat-1 cells were propagated in Dulbecco's MEM supplemented with 5 % fetal calf serum. Two days after transfection, 600 lag/ml G418 (Gibco) was added to the culture medium. After 2 to 3 weeks, individual G41g-resistant colonies were isolated and tested by hybridization and immunofluorescence, as described previously (Friedrich et al., 1991) . Positive cell lines were superinfected with Friend murine leukaemia virus 22N (F-MuLV; Ostertag et al., 1980) , a highly effective helper virus for SFFV.
Immune precipitation. Cells were labelled in 35 mm dishes with 100 laCi [aSS]methionine (1000 Ci/mmol, Amersham) for 1 h. After labelling, the cells were washed twice with PBS and incubated on ice for 15 min in 250 gl extraction buffer (Friedrich et al., 1991) . The extracted supernatants were clarified by centrifugation at 13 000 g for 10 min at 0 °C. Samples of 50 gl of labelled cell extracts were mixed with anti-gp70 rabbit serum (kindly provided by H. Bauer) and heatinactivated Staphylococcus aureus (Calbiochem) for 3 h at 4 °C. Immune precipitates were isolated by centrifugation, washed twice with extraction buffer and resuspended in 50 lal buffer containing 125 mMTris-HC1 pH 6"8, 4% SDS, 2% 2-mercaptoethanol, 10% glycerol and bromophenol blue). The samples were boiled for 5 min before they were loaded onto 10% SDS-polyacrylamide gels.
Digestion of carbohydrates with glycopeptidase F. For the removal of N-linked oligosaccharides, immunoprecipitates were, after washing with extraction buffer and 10 mM-Tris-HC1 pH 7.2, resuspended in 100 pl of buffer containing 25 mM-sodium phosphate pH 7.2, 0"6% Nonidet P40 and incubated for 48 h at 37 °C with 15 mU glycopeptidase F (EC 3.5.1.52, N-glycosidase F; Boehringer).
Infection of mice.
To test the biological activity, virus stocks containing recombinant virus and the helper virus F-MuLV 22N were injected into the tail veins of 6 to 10 week old DBA/2J mice. At least six animals were infected with each viral construct. To ensure that equal amounts of virus were injected, SFFV RNAs prepared from cellular supernatants were quantified by hybridization according to the method of Paeratakul et al. (1988) . Three to 6 weeks after infection, mice were killed and their spleen weights and haematocrit levels were determined. Spleens were fixed in Bouin's solution and then examined for foci.
Results

Construction of glycosylation mutants
To determine the role of gp55 N-glycosylation in pathogenicity, we modified the four known N-glycosylation sites, replacing the asparagine residues with Fig. 1 illustrates the various Env-derived proteins investigated.
Biochemical characterization of mutated env gene products
The env gene products of the wild-type and the various mutated viruses were characterized by immunoprecipitation after the cells had been labelled with [~sS]-methionine. Fig. 2 and Table 1 To determine whether the additional protein bands observed in the case of mutants lacking glycosylation site 3 (Asn297) carried an additional N-linked oligosaccharide side-chain, the immunoprecipitates of gm 1.2.3-, gml. 2.4-and gm. all-transfected cells were treated with glycopeptidase F prior to SDS-PAGE. Although removal of the sugar side-chains by this enzyme was usually incomplete the results revealed products missing all four N-linked oligosaccharide side-chains (marked '-4' in Fig. 3 ) in all cases. In the case of the Env-derived protein ofgm. all, a complete conversion of the 47.5K band into the 45K polypeptide was observed.
Pathogenicity of the glycosylation mutants
All molecular clones were tested in DBA/2J mice for pathogenicity. Mice were sacrificed either 3, 4 or 6 weeks after infection and their spleen weights, haematocrit levels and the number of spleen foci were determined.
The mutants gml, gm2 and gml.2 showed disease parameters very similar to those of wild-type virus. All mutants involving glycosylation sites 3 or 4, however, were non-pathogenic (see Fig. 4 for spleen weights and foci). Haematocrit levels of diseased animals were 72 to 80%, whereas those of uninfected control animals or animals infected with non-pathogenic mutants were 47 to 55%.
Discussion
Little is known about the roles of individual Nglycosylation sites of the Env-related product of SFFV in viral pathogenicity. To determine whether the N-linked carbohydrate side-chains exert an influence on the biological properties of this protein, we constructed virus mutants encoding glycoproteins in which asparagine residues of Asn-X-Ser/Thr glycosylation sequences were replaced by serine. We chose serine because its size and polarity are similar to those of asparagine. The four glycosylation sites were mutated either individually or in combinations of two, three or all four sites as shown in Fig. 1 . All mutations were verified by restriction enzyme analysis and sequencing (see Methods).
Removal of each glycosylation site led to a reduction in the apparent M r of the mutated protein by about 2.5K which roughly corresponds to the M,. of a high-mannose type carbohydrate side-chain (Polonoff et al., 1982) (Fig.   2) . Thus, mutation of a single glycosylation site (mutants gml, gm2, gin3 or gin4) resulted in proteins that all migrated according to an apparent Mr of about 52"5K in SDS-PAGE indicating the loss of one side-chain. In the case of mutant gm3, a second polypeptide band was detectable which migrated at the position of the Envderived protein carrying four carbohydrate side-chains. Similar results were obtained for all other glycosylation mutants in which the third glycosylation site of the Envderived protein was destroyed (gm3.4, gml.2.3 and gm. all) . All of these mutants were characterized by a second band at the position of a protein containing one additional sugar chain. Six to 10 independent clones from each construct were tested by immunoprecipitation with similar results, thus making contamination of the mutants with revertants very unlikely. All tests confirmed that a number of mutant glycoproteins, in which the glycosylation site 3 was destroyed, had acquired a new carbohydrate side-chain at a position that is not normally used for carbohydrate substitution. The sensitivity of the additional gene products to glycopeptidase F (Fig. 3) further corroborated the carbohydrate nature of this substituent.
Sequencing of some mutants excluded the possibility that new glycosylation consensus sequences were introduced unintentionally by the numerous cloning steps and made it likely that the additional protein represents a product glycosylated at the fifth N-glycosylation site that is not active normally. It seems possible that the absence of the side-chain at the third site leads to a conformational change of the protein allowing glycosylation of the fifth potential site.
Mutation of one of the first two glycosylation sites, or both, did not have any influence on the pathogenicity of the mutant viruses. However, removal of the third or fourth consensus sequence completely abolished induction of leukaemia following infection with the mutant viruses. Any construct in which either the third or fourth glycosylation site, or both, was missing were fully apathogenic. Mice were kept for up to 6 months and did not show any sign of disease (some mice infected with
gm. all were also tested 12 months after infection).
The Env-related protein of SFFV has been shown to play a central role in the pathogenicity of this virus.
In agreement with corresponding studies on gp71 of F-MuLV (Kayman et al., 1991) , our data suggest that N-glycosylation is required for pathogenicity and that the carbohydrate side-chains are important for correct folding and/or processing of the Env-related protein. It is also conceivable that the amino acid sequence at these sites may itself be critical for the pathogenic properties of the protein. Preliminary results with a construct carrying an Asn-to-Asp exchange at site 3 show that this mutation does not have such a striking effect on viral pathogenicity. The presence of a carbohydrate side-chain at one site and the correct amino acid sequence at a second site may be important for the proper folding or processing of the protein. Further work is in progress to investigate whether incomplete glycosylation of the Envrelated protein may impair its intracellular transport.
